ANI Pharmaceuticals, Inc. (ANIP) vs Certara, Inc. (CERT)
A side-by-side comparison of ANI Pharmaceuticals, Inc. and Certara, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIP
ANI Pharmaceuticals, Inc.
$72.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CERT
Certara, Inc.
$10.07HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ANIP vs CERT
growth of $100 · dividends reinvested · last 6yANIP +144.8% (+16.1%/yr)CERT -73.6% (-19.9%/yr)ANIP compounded faster over this window
Log scale — wide-divergence pair
ANIP CERT
ANIP vs CERT: by the numbers
- •ANIP is the larger company ($1.65B vs $1.57B market cap).
- •ANIP is profitable (10.82% net margin) while CERT runs a net loss (-16.75%).
- •ANIP grew revenue faster over the past five years (35.61% vs 9.31% CAGR).
Metrics side by side
Valuation
| Metric | ANIP | CERT |
|---|---|---|
| P/E ratio | 15.68 | N/A |
| Forward P/E | 7.83 | 29.56 |
| P/S ratio | 1.69 | 3.84 |
| P/B ratio | 2.76 | 1.62 |
| EV / EBITDA | 6.87 | 28.35 |
| FCF yield | N/A | 3.93% |
Profitability
| Metric | ANIP | CERT |
|---|---|---|
| Gross margin | 51.01% | 58.33% |
| Operating margin | 15.35% | 1.86% |
| Net margin | 10.82% | -16.75% |
| ROE | 17.72% | -7.08% |
| ROIC | 9.26% | 0.59% |
Growth (annualized)
| Metric | ANIP | CERT |
|---|---|---|
| Revenue CAGR (5Y) | 35.61% | 9.31% |
| FCF CAGR (5Y) | N/A | 8.78% |
| Total return CAGR (5Y) | 16.86% | -21.31% |
Frequently asked
- Which has grown faster, ANIP or CERT?
- Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus CERT at 9.31%.
- Is ANIP or CERT more profitable?
- ANIP runs the higher net margin — ANIP at 10.82% versus CERT at -16.75%.
- How have ANIP and CERT total returns compared?
- Over the past 5 years, ANIP delivered 16.86% and CERT delivered -21.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ANI Pharmaceuticals P/E ratioANI Pharmaceuticals ROECertara ROEANI Pharmaceuticals operating marginCertara operating marginANI Pharmaceuticals revenue growthCertara revenue growthANI Pharmaceuticals free cash flowCertara free cash flow
ANI Pharmaceuticals & Certara appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.